Diabetes, Metformin, and Cancer Risk in Myotonic Dystrophy Type I

Myotonic dystrophy Type I (DM1) is an autosomal dominant multi-system disorder characterized by myotonia and muscle weakness. Type 2 diabetes (T2D) and cancer have been shown to be part of the DM1 phenotype. Metformin, a well-established agent for the management of T2D, is thought to have cancer-pre...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Int J Cancer
Asıl Yazarlar: Alsaggaf, Rotana, Pfeiffer, Ruth M., Wang, Youjin, St. George, Diane Marie M., Zhan, Min, Wagner, Kathryn R., Amr, Sania, Greene, Mark H., Gadalla, Shahinaz M.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2019
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7336337/
https://ncbi.nlm.nih.gov/pubmed/31749144
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ijc.32801
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller